本地传播在加拿大移民耐多药结核病中无重要作用
该研究回顾性分析加拿大某省1982-2001和2002-2019两个时期移民结核病患者,发现耐多药结核比例从0.6%升至2.0%,其中31.6%归因于近期移民,68.4%归因于高耐多药负担国家病例中耐多药比例升高,无病例归因于本地传播。
要点
- 移民耐多药结核增加主要源于高负担国家输入,非本地传播。
- 高耐多药负担国家移民中耐多药比例从1.11%升至3.62%。
- 需加强高耐多药负担国家的结核病规划。
核心结论
- 在加拿大,本地传播对耐多药结核病的发生无重要作用,与高耐多药负担国家形成鲜明对比。
研究设计与样本
- 加拿大某省回顾性队列研究,比较1982-2001年与2002-2019年移民结核病患者。
主要发现
- 耐多药结核增加中31.6%归因于近期移民,68.4%归因于出生国病例中耐多药比例升高。
- 无耐多药结核病例归因于本地传播。
临床怎么用
- 临床应对来自高耐多药负担国家的移民结核患者保持耐多药警惕,并加强原籍国结核病控制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multidrug-resistant (MDR) tuberculosis has increased among migrants in Canada. The cause(s) of this increase is unknown. METHODS: We performed a retrospective cohort study in a Canadian province with substantially increased immigration between 1982-2001 and 2002-2019. The proportion of MDR tuberculosis among migrants arriving from high MDR (HMDR) tuberculosis burden countries during these 2 periods was used to estimate the proportion of cases due to immigration versus change in proportion in the country of birth. Epidemiologic, spatiotemporal, and drug resistance pattern data were used to confirm local transmission. RESULTS: Fifty-two of 3514 (1.48%) foreign-born culture-positive tuberculosis patients had MDR tuberculosis: 8 (0.6%) in 1982-2001 and 44 (2.0%) in 2002-2019. Between time periods, the proportion of MDR tuberculosis among migrants with tuberculosis from HMDR tuberculosis countries increased from 1.11% to 3.62%, P = .003; 31.6% attributable to recent immigration and 68.4% to a higher proportion of MDR tuberculosis in cases arrived from HMDR tuberculosis countries. No cases of MDR tuberculosis were attributable to local transmission. CONCLUSIONS: In stark contrast to HMDR tuberculosis countries, local transmission plays no important role in the occurrence of MDR tuberculosis in Canada. Improved tuberculosis programming in HMDR tuberculosis countries is urgently needed.
引用
- Long R, Lau A, Egedahl ML, et al. Local Transmission Plays No Important Role in the Occurrence of Multidrug-Resistant Tuberculosis in Immigrants to Canada: An In-depth Epidemiologic Analysis. J Infect Dis. 2021. PMID: 33502538. doi:10.1093/infdis/jiab045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。